TTK Healthcare Reports Q2 EBITDA Of ₹3.7 Crore With 1.6% Margin

Market snapshot: TTK Healthcare reported its second-quarter operating performance, showing a decline in operating profit and margin compression YoY. Operating EBITDA came in at ₹3.70 crore, compared to ₹5.33 crore in the corresponding quarter of the previous financial year.

Data Snapshot

• Q2 EBITDA stood at ₹3.70 crore compared to ₹5.33 crore in the year-ago period.
• Q2 EBITDA margin contracted to 1.60% from 2.62% YoY.

What's Changed

• Operating EBITDA decreased by ≈30.58% YoY to ₹3.70 crore from ₹5.33 crore.
• EBITDA margin contracted by 102 basis points YoY to 1.60% from 2.62%.

Key Takeaways

• Operating profit recorded a noticeable compression compared to the same period last year.
• Margin trajectory indicates cost pressures impacting underlying EBITDA yield.
• Recent strategic business restructuring follows the divestment of key personal care brands.

SAHI Perspective

The compression in operating EBITDA and EBITDA margin reflects ongoing operational realignments within TTK Healthcare's key segments. Investors should monitor how portfolio rationalization, following recent divestments, impacts medium-term profitability.

Market Implications

Contracting operating margins may weigh on near-term trading sentiment for the stock until top-line recovery or cost optimization measures stabilize operating earnings.

Trading Signals

Market Bias: Bearish

Operating performance weakened YoY as Q2 EBITDA dropped to ₹3.70 crore alongside a 102 bps margin contraction to 1.60%.

Underweight: Pharmaceuticals & Healthcare

Trigger Factors:

• Quarterly margin stabilization in upcoming earnings reports
• Impact of cash proceeds from divestments on working capital

Time Horizon: Near-term (0-3 months)

Industry Context

Mid-tier healthcare and consumer healthcare businesses in India face variable input costs and distribution restructuring, impacting quarter-on-quarter EBITDA margins across non-core product portfolios.

Key Risks to Watch

• Further operating margin contraction if raw material and freight costs remain elevated
• Slower-than-expected earnings turnaround following recent consumer brand divestments

Recent Developments

Wipro Consumer Care acquired TTK Healthcare's Good Home and Eva brands for ₹256 crore in July 2026.

Closing Insight

A sustained margin expansion plan will be vital for TTK Healthcare to restore operating leverage in coming quarters.

High Performance Trading with SAHI.